The Gross Margin of Novelix Pharmaceuticals Ltd (536565.BO) is 9.17%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-03-31 | 9.17% |
| 2023-03-31 | 3.73% |
| 2022-03-31 | 4.15% |
| 2021-03-31 | 7.32% |
| 2020-03-31 | 10.52% |
| 2019-03-31 | 13.54% |
| 2018-03-31 | 16.67% |
| 2017-03-31 | 15.52% |
| 2016-03-31 | 28.05% |
| 2015-03-31 | 27.64% |